New Zealand Contrast Agents Market Outlook to 2022 - Product Image

New Zealand Contrast Agents Market Outlook to 2022

  • ID: 4394174
  • Report
  • Region: New Zealand
  • 46 pages
  • GlobalData
1 of 3
New Zealand Contrast Agents Market Outlook to 2022

Summary

The new report, "New Zealand Contrast Agents Market Outlook to 2022", provides key market data on the New Zealand Contrast Agents market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles).

*Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends)

The report also provides company shares and distribution shares data for the market segment, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to market size, company share, pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. The author uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size for Contrast Agents market segments Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles).
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market segments. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for Contrast Agents market.
  • Global corporate-level profiles of key companies operating within the New Zealand Contrast Agents market.
  • Key players covered include GE Healthcare Limited, Bracco Imaging S.p.A. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Contrast Agents Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Contrast Agents Market, New Zealand
3.1 Contrast Agents Market, New Zealand, Revenue ($m), 2008-2015
3.2 Contrast Agents Market, New Zealand, Revenue ($m), 2015-2022
3.2.1 Computed Tomography (CT) Contrast Agents Market, New Zealand, Revenue ($m), by Segment, 2008-2015
3.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Revenue ($m), by Segment, 2008-2015
3.2.3 Computed Tomography (CT) Contrast Agents Market, New Zealand, Revenue ($m), by Segment, 2015-2022
3.2.4 Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Revenue ($m), by Segment, 2015-2022
3.3 Contrast Agents Market, New Zealand, Volume (Units), 2008-2015
3.4 Contrast Agents Market, New Zealand, Volume (Units), 2015-2022
3.4.1 Computed Tomography (CT) Contrast Agents Market, New Zealand, Volume (Units), by Segment, 2008-2015
3.4.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Volume (Units), by Segment, 2008-2015
3.4.3 Computed Tomography (CT) Contrast Agents Market, New Zealand, Volume (Units), by Segment, 2015-2022
3.4.4 Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Volume (Units), by Segment, 2015-2022
3.5 Contrast Agents Market, New Zealand, Average Price ($), 2008-2022
3.6 Contrast Agents Market, New Zealand, Average Price ($), by Segment 2008-2022
3.7 Contrast Agents Market, New Zealand, Distribution Share by Revenue ($m), 2014-2015
3.8 Contrast Agents Market, New Zealand, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in New Zealand, Contrast Agents Market
4.1 GE Healthcare LLC
4.1.1 Company Overview
4.2 Guerbet SA
4.2.1 Company Overview
4.3 Bracco Imaging SpA
4.3.1 Company Overview
4.4 Lantheus Medical Imaging Inc
4.4.1 Company Overview
5 Contrast Agents Market Pipeline Products
6 Financial Deals Landscape
6.1 Partnerships
6.1.1 Telix Pharma Enters into Licensing Agreement with Wilex
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Company Share Analysis
7.1.5 Distribution Share Analysis
7.1.6 Benchmarking
7.2 Consulting
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015
Table 2: Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 3: Computed Tomography (CT) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015
Table 5: Computed Tomography (CT) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 6: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 7: Contrast Agents Market, New Zealand, Volume (Units), Historic, 2008-2015
Table 8: Contrast Agents Market, New Zealand, Volume (Units), Forecast, 2015-2022
Table 9: Computed Tomography (CT) Contrast Agents Market, New Zealand, Volume (Units), Historic, 2008-2015
Table 10: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Volume (Units), Historic, 2008-2015
Table 11: Computed Tomography (CT) Contrast Agents Market, New Zealand, Volume (Units), Forecast, 2015-2022
Table 12: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Volume (Units), Forecast, 2015-2022
Table 13: Contrast Agents Market, New Zealand, Average Price ($), Historic, 2008-2015
Table 14: Contrast Agents Market, New Zealand, Average Price ($), Forecast, 2015-2022
Table 15: Contrast Agents Market, New Zealand, Average Price ($) Historic, 2008-2022
Table 16: Contrast Agents Market, New Zealand, Average Price ($), Forecast, 2015-2022
Table 17: Contrast Agents Market, New Zealand, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 18: Contrast Agents Market, New Zealand, Company Share by Revenue ($m), USD Constant, 2015
Table 19: Contrast Agents Market Pipeline Products
Table 20: Telix Pharma Enters into Licensing Agreement with Wilex

List of Figures
Figure 1: Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Computed Tomography (CT) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 5: Computed Tomography (CT) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 6: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 7: Contrast Agents Market, New Zealand, Volume (Units), Historic, 2008-2015
Figure 8: Contrast Agents Market, New Zealand, Volume (Units), Forecast, 2015-2022
Figure 9: Computed Tomography (CT) Contrast Agents Market, New Zealand, Volume (Units), Historic, 2008-2015
Figure 10: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Volume (Units), Historic, 2008-2015
Figure 11: Computed Tomography (CT) Contrast Agents Market, New Zealand, Volume (Units), Forecast, 2015-2022
Figure 12: Magnetic Resonance Imaging (MRI) Contrast Agents Market, New Zealand, Volume (Units), Forecast, 2015-2022
Figure 13: Contrast Agents Market, New Zealand, Company Share (%) 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll